Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
MCP Digital Health Home
Close
  • Home
  • Articles & Issues
    • Back
    • COVID Articles In Press
    • Issue In Progress
    • Current Issue
    • List of Issues
  • Collections
    • Back
    • Case Reports
    • Commentaries
    • Editorials
  • For Authors
    • Back
    • Submit a Manuscript 
    • Author Information
    • Open Access Options 
    • Permissions
    • Researcher Academy
  • Journal Info
    • Back
    • About the Journal
    • Contact Editorial Office
    • Editorial Board
    • Reprints 
    • New Content Alerts
  • Companion Titles
    • Back
    • Mayo Clinic Proceedings 
    • MCP: Digital Health 
  • Mayo Clinic
    • Back
    • Home 
    • Mayo Clinic Resources
    • Mayo Clinic Marketplace 
    • Online Services for Medical Professionals 
    • Continuing Medical Education 
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
Skip menu

    Login to your account

    Show
    Forgot password?
    Don’t have an account?
    Create a Free Account

    If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

    If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

    Cancel
    x

    Filter:

    Filters applied

    • Case Reports
    • 2021 - 2023Remove 2021 - 2023 filter
    Clear all

    Article Type

    • Case Reports8

    Author

    • Hogan, Breann M2
    • Loftus, Conor G2
    • Nasser-Ghodsi, Navine2
    • Reed, Jamie M2
    • Ackermann, Ronald T1
    • Amin, Alpesh1
    • Anderson, Jason H1
    • Bhatt, Shubhang K1
    • Chinn, Justine1
    • Cooper, Andrew J1
    • Dawit, Sara1
    • Gilmer, Amy1
    • Greenmyer, Jacob R1
    • Herrmann, Sandra M1
    • Hohmann, Samuel1
    • Kang, Raymond H1
    • Kohorst, Mira A1
    • Lang, Daenielle K1
    • Leung, Nelson1
    • Liss, David T1
    • Markovic, Svetomir N1
    • McCoy, Christopher P1
    • Meehan, Anne M1
    • Nguyen, Ninh T1
    • Niaz, Talha1

    Journal

    • Mayo Clinic Proceedings: Innovations, Quality & Outcomes 8

    Keyword

    • computed tomography2
    • coronavirus disease 20192
    • COVID-192
    • CT2
    • AMC1
    • ASM1
    • AVV1
    • BAO1
    • C-reactive protein1
    • CFX1
    • CLS1
    • CRP1
    • CST1
    • DM1
    • DPP-41
    • EEG1
    • EVALI1
    • GLP-11
    • ICD-91
    • IL1
    • INR1
    • International Classification of Diseases, Ninth Revision1
    • IRR1
    • IV1
    • IVIG1

    Access Filter

    • Open Access

    Case Reports

    8 Results
    Subscribe to collection
    • Export
      • PDF
      • Citation

    Please select at least one article in order to proceed.

    Ok
    FilterHide Filter
    • Case report
      Open Access

      Chromogenic Factor X Assay for Monitoring Warfarin Anticoagulation in a Child With a Prosthetic Mitral Valve

      Mayo Clinic Proceedings: Innovations, Quality & Outcomes
      Vol. 5Issue 5p811–816Published online: August 10, 2021
      • Jacob R. Greenmyer
      • Talha Niaz
      • Mira A. Kohorst
      • Elizabeth H. Stephens
      • Jason H. Anderson
      Cited in Scopus: 0
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        Mechanical mitral valve replacement in infants and young children is associated with substantial morbidity and mortality. Lifelong anticoagulation is required, with all the accompanying challenges of maintaining levels in infants and children whose dietary input continually changes. Even with careful control of all aspects that can perturb the coagulation cascade, these patients have a substantial lifelong risk of thrombotic and hemorrhagic complications that can also affect the durability of the valve.
        Chromogenic Factor X Assay for Monitoring Warfarin Anticoagulation in a Child With a Prosthetic Mitral Valve
      • Case report
        Open Access

        Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction

        Mayo Clinic Proceedings: Innovations, Quality & Outcomes
        Vol. 5Issue 3p670–674Published online: June 7, 2021
        • Haixia Qin
        • Brittany Vlaminck
        • Itunu Owoyemi
        • Sandra M. Herrmann
        • Nelson Leung
        • Svetomir N. Markovic
        Cited in Scopus: 0
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          Although capillary leak syndrome has a high mortality rate, its trigger, diagnosis, and treatment remain a challenge to clinicians because of the poor understanding of its mechanism and lack of treatment guidelines. With the extended use of immune checkpoint inhibitors in modern oncology, immune checkpoint inhibitor–associated immune-related adverse events have also expanded. We present a case of pembrolizumab-induced capillary leak syndrome and lymphatic capillary dysfunction in which the patient had an excellent clinical response to a tailored treatment strategy.
          Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction
        • Case report
          Open Access

          Glycemic Outcomes of Second-Line Diabetes Drug Choice in a Real-World Population

          Mayo Clinic Proceedings: Innovations, Quality & Outcomes
          Vol. 5Issue 3p675–681Published online: May 26, 2021
          • Amisha Wallia
          • Matthew J. O’Brien
          • David T. Liss
          • Raymond H. Kang
          • Andrew J. Cooper
          • Amy Gilmer
          • and others
          Cited in Scopus: 0
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            Hypoglycemia and acute metabolic complications (AMCs; ketoacidosis, hyperosmolarity, and coma) are glycemic outcomes that have high cost and high morbidity; these outcomes must be taken into consideration when choosing initial second-line therapy after metformin. We conducted a retrospective cohort study analyzing national administrative data from adults with type 2 diabetes mellitus who started a second-line diabetes medication (sulfonylureas [SFUs], thiazolidinediones [TZDs], glucagon-like peptide 1 [GLP-1] agonists, dipeptidyl peptidase 4 [DPP-4] inhibitors, basal insulin, or sodium-glucose contransporter 2 [SGLT-2] inhibitors) between April 1, 2011 and September 30, 2015 (N=43,288) and compared rates of hypoglycemia and AMCs.
          • Case report
            Open Access

            Management of Hypertriglyceridemia-Induced Acute Pancreatitis in a Nondiabetic Patient

            Mayo Clinic Proceedings: Innovations, Quality & Outcomes
            Vol. 5Issue 2p520–524Published online: April 7, 2021
            • Jamie M. Reed
            • Breann M. Hogan
            • Navine Nasser-Ghodsi
            • Conor G. Loftus
            Cited in Scopus: 0
            • Preview Hide Preview
            • Download PDF
            • Export Citation
              Treatment strategies for hypertriglyceridemia-induced acute pancreatitis are not well defined in the current literature or guidelines. One therapeutic option is an insulin infusion accompanied by a dextrose infusion to avoid hypoglycemia. The purpose of this case report is to highlight dosing considerations for dextrose infusions in nondiabetic patients. We describe a case of hypertriglyceridemia-induced acute pancreatitis in a 34-year-old nondiabetic woman treated with a reduced-dose insulin infusion that was complicated by hypoglycemic episodes requiring dextrose infusion titrations.
              Management of Hypertriglyceridemia-Induced Acute Pancreatitis in a Nondiabetic Patient
            • Case report
              Open Access

              EVALI: A Mimicker of COVID-19

              Mayo Clinic Proceedings: Innovations, Quality & Outcomes
              Vol. 5Issue 3p682–687Published online: March 29, 2021
              • Mitchell M. Pitlick
              • Daenielle K. Lang
              • Anne M. Meehan
              • Christopher P. McCoy
              Cited in Scopus: 0
              • Preview Hide Preview
              • Download PDF
              • Export Citation
                E-cigarette or vaping product use–associated lung injury (EVALI) is a respiratory illness that has significant overlap with the symptoms of coronavirus disease 2019 (COVID-19). In the current pandemic, diagnosis of EVALI may be delayed because of anchoring bias when patients present with symptoms consistent with COVID-19. We present 3 cases of patients who were hospitalized with a presumed diagnosis of COVID-19 but were later diagnosed with EVALI.
                EVALI: A Mimicker of COVID-19
              • Case report
                Open Access

                The Impact of COVID-19 on Volume of Inpatient Hospitalization Through General Medicine and Medicine Subspecialty Services at US Medical Centers

                Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                Vol. 5Issue 2p516–519Published online: March 3, 2021
                • Justine Chinn
                • Andrew Ramirez
                • Samuel Hohmann
                • Alpesh Amin
                • Ninh T. Nguyen
                Cited in Scopus: 0
                • Preview Hide Preview
                • Download PDF
                • Export Citation
                  As the coronavirus disease 2019 pandemic continues to impact hospital systems both in the United States and throughout the world, it is important to understand how the pandemic has impacted the volume of hospital admissions. Using the Vizient Inc (Chicago, IL) clinical databases, we analyzed inpatient hospital discharges from the general medicine service and its subspecialty services including cardiology, neonatology, pulmonary/critical care, oncology, psychiatry, and neurology between December 2019 and July 2020.
                  The Impact of COVID-19 on Volume of Inpatient Hospitalization Through General Medicine and Medicine Subspecialty Services at US Medical Centers
                • Case report
                  Open Access

                  Refractory Left Focal Motor Status Epilepticus as Initial Clinical Presentation of Acute Basilar Artery Thrombosis

                  Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                  Vol. 5Issue 2p511–515Published online: February 11, 2021
                  • Shubhang K. Bhatt
                  • Sara Dawit
                  • Erin M. Okazaki
                  • Katherine H. Noe
                  Cited in Scopus: 0
                  • Preview Hide Preview
                  • Download PDF
                  • Export Citation
                    Seizures are uncommon with posterior circulation strokes. They are more often associated with anterior circulation strokes, with only a limited number of cases of status epilepticus reported to be related to brain stem ischemia. The literature includes case reports of generalized tonic-clonic seizures and associated status epilepticus as an initial presentation of acute basilar artery thrombosis. However, there are only rare cases reporting focal motor seizure as status epilepticus in the setting of acute basilar artery thrombosis, an important clinical presentation that should prompt evaluation for acute brain stem ischemia.
                    Refractory Left Focal Motor Status Epilepticus as Initial Clinical Presentation of Acute Basilar Artery Thrombosis
                  • Case report
                    Open Access

                    Management of Hypertriglyceridemia-Induced Acute Pancreatitis in a Nondiabetic Patient

                    Mayo Clinic Proceedings: Innovations, Quality & Outcomes
                    Vol. 5Issue 1p230–235Published in issue: February, 2021
                    • Jamie M. Reed
                    • Breann M. Hogan
                    • Navine Nasser-Ghodsi
                    • Conor G. Loftus
                    Cited in Scopus: 0
                    • Preview Hide Preview
                    • Download PDF
                    • Export Citation
                      Hypertriglyceridemia-induced acute pancreatitis treatment strategies are not well defined in current literature or guidelines. One therapy option is an insulin infusion accompanied by a dextrose infusion to avoid hypoglycemia. The purpose of this case report is to highlight dosing considerations for dextrose infusions in nondiabetic patients. We describe a case of hypertriglyceridemia-induced acute pancreatitis in a 34-year-old nondiabetic female patient treated with a reduced-dose insulin infusion, complicated by hypoglycemic episodes requiring dextrose infusion titrations.
                      Management of Hypertriglyceridemia-Induced Acute Pancreatitis in a Nondiabetic Patient
                    Page 1 of 1
                    • Home
                    • Articles & Issues
                    • COVID Articles in Press
                    • Issue In Progress
                    • Current Issue
                    • List of Issues
                    • Collections
                    • Case Reports
                    • Commentaries
                    • Editorials
                    • For Authors
                    • Submit a Manuscript
                    • Author Information
                    • Open Access Options
                    • Permissions
                    • Researcher Academy
                    • Journal Info
                    • About the Journal
                    • Contact Editorial Office
                    • Editorial Board
                    • Reprints
                    • New Content Alerts
                    • Companion Titles
                    • Mayo Clinic Proceedings
                    • MCP: Digital Health
                    • Mayo Clinic
                    • Home
                    • Mayo Clinic Resources
                    • Mayo Clinic Marketplace
                    • Online Services for Medical Professionals
                    • Continuing Medical Education
                    • Follow Us
                    • YouTube
                    • Twitter
                    We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
                    Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.

                    • Privacy Policy  
                    • Terms and Conditions  
                    • Accessibility  
                    • Help & Contact

                    RELX